Hepatocyte growth factor (HGF) and its receptor c-met are also known to activate ERK5 and upregulate one of the downstream targets fos-related antigen-1 (FRA-1) via PI3K-AKT signaling in malignant mesotheliomas (MMs) [31]. The gene discussed is HGF; the disease is malignant mesothelioma.